Recruiting

90Second Caregiver

Sponsor:

IWK Health Centre

Code:

NCT05882461

Conditions

Caregivers

Acquired Brain Injury

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

90Second Caregiver health letter

Study Details

Brief summary:

The purpose of the present study is to conduct a two-arm Randomized Control Trial (RCT) comparing individuals receiving the 90Second Caregiver health letter, with a usual care (routine care received by caregivers) control group.

The goals of the present study are:

  • To evaluate the effectiveness of the 90Second Caregiver health letter in improving caregiver's self-efficacy (primary outcome), savouring, and quality of life (secondary outcomes).
  • To evaluate the effectiveness of the 90Second Caregiver health letter in reducing caregiver's psychological strain and caregiver burden (secondary outcomes).
  • To examine the impact of levels of engagement with the 90Second Caregiver health letter on primary and secondary outcomes.
  • To assess the usability of the 90Second Caregiver health letter, as it relates to the relevance of topic, user friendliness, and appropriateness of the readability levels.
  • To evaluate psychometric properties of self-constructed measures in 90Second newsletter.

Conditions

Caregivers

Acquired Brain Injury

Study ID

NCT05882461

Start date

Feb 17, 2021

Status verified date

May, 2023

Completion date

Mar, 2024

Anticipated

Primary completion date

Mar, 2024

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Participant is currently enrolled in the Caring Forward Trials within Cohort study (REB#1025253)
  • Participant has agreed to be contacted for future studies by Dr. McGrath's staff
  • Participant has agreed for their data to be used for future studies
  • Participant has mild levels of distress, as indicated by mild scores on the DASS-21 and/or the ZBI-SF

Exclusion Criteria:

  • Participant is NOT currently enrolled in the Caring Forward Trials within Cohort study (REB#1025253)
  • Participant has NOT agreed to be contacted for future studies by Dr. McGrath's staff
  • Participant has NOT agreed for their data to be used in future studies
  • Participant does NOT report mild levels of distress, as indicated by mild scores on the DASS-21 and/or the ZBI-SF

Study Design

Enrollment

330 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: Those receiving the 90Second Caregiver health letter

The 90Second Caregiver health letter is a weekly online publication that addresses topics relevant for caregivers. It combines scientifically-valid, evidence-based information with actionable tips to improve caregiver self efficacy and well-being. Participant in this group will receive a 90Second Caregiver health letter every week, via email.

no intervention: The usual care control group

Participants that are randomized to be in the usual care control group will continue on as participants in the Caring Forward Trials within Cohort Study (i.e. filling out questionnaires every 6-months). Participants will continue to participate in the Caring Forward Study until completion in March 2022.

Interventions

90Second Caregiver health letter

Participant receives the weekly health letter via email

Primary outcome measure

  • Caregiving self-efficacy [ Time Frame: [Time Frame: At baseline.] ]
  • Caregiving self-efficacy [ Time Frame: [Time Frame: Six months following baseline.] ]
  • Caregiving self-efficacy [ Time Frame: [Time Frame: Twelve months following baseline.] ]
  • Caregiving self-efficacy [ Time Frame: [Time Frame: Eighteen months following baseline.] ]
  • Caregiving self-efficacy [ Time Frame: [Time Frame: Twenty four months following baseline.] ]

Central Contacts and Locations

Locations

IWK Health Centre

Recruiting

Halifax, Nova Scotia, Canada

Contacts

Andre Lauzon

(902) 470-8160Andre.Lauzon@iwk.nshealth.ca

Principal Investigator:

Patrick McGrath

More Information

Sponsor

IWK Health Centre

Last update posted

May 31, 2023

Last verified

May, 2023

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by IWK Health Centre on 2023-05-31.